DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20160307

Neurocysticercosis: clinical presentations, serology and radiological findings: experience in a teaching institution

Balvinder S. Arora, Kamakshi Dhamija

Abstract


Background: The objective of the study was to study the clinical presentations, serological evidence and radiological findings in cases of neurocysticercosis in a teaching institution with attached tertiary care hospital settings.

Methods: A total of 60 paediatric age group patients were enrolled in the study and their clinical presentations, serological profile and radiological findings were recorded. Study data was evaluated in a retrospective analysis of the descriptive hospital based observational study conducted at Safdarjang hospital (SJ) hospital, New Delhi.

Results: Generalised seizures were the most predominant clinical presentation in 28/60 cases (47%). Majority of the patients had single lesions in parietal lobe in CT head. 90% of the patients showed perilesional oedema on CT scan. Differences in IgG positivity rate in the various age groups were not significant either for serum or CSF - the p values were 0.67 & 0.052 respectively. Seropositivity was also not significantly associated with presence of active NCC lesions on CT (p= 0.254). In further analysis, diet was not found to have any significant influence on either seropositivity (p value=0.673) or on the pattern of presentation on CT (p=0.260). NBM-It is disappointing to know that only 20% urban 45%rural is aware of 8 hours NBM before surgery.

Conclusions: Observations suggest there is variability in the clinical, serological and radiological presentation of neurocysticercosis when compared with standard criteria.

 


Keywords


Neurocysticercosis, Seizures, Serology, Albendazole

Full Text:

PDF

References


Alarcon F. Neurocysticercosis: its aetiopathogenesis, clinical manifestations, diagnosis, and treatment. Rev Neurol. 2006;43: S93-00.

Kalra S, Jaiswal AK, Behari S, Jain VK. Lateral ventricular neurocysticercosis: A case report. Indian J Radiolimaging. 2006;16:775-8.

Psarras TG, Zour A, Coimbra C. Neurocysticercosis. A neurosurgical perspective. South Med J. 2003;96(10):1019-22.

Garcia HH, Evans CAW, Nash TE. Current consensus guidelines for treatment of neurocysticercosis. ClinMicrobiol Rev. 2002;15:747-56.

Reddy BA, Chitgope R, Rao SN, Eluzai Z, Mugdalimath AB, Sane MR. A study of clinical perspective and aetiology of ring enhancing lesions in computerized tomography scan brain in children. Int J Med Pharm Sci. 2014;04(07):1-3.

Garcia HH, Evans CAW, Nash TE. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev. 2002;15:747-56.

Del Brutto OH, Rajshekhar V, White AC, Tsang VC, Nash TE, Takayanagui OM. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001;57:177-83.

Singh G, Singh I, Rani A, Kaushal S, Avathi G. Epidemiologic classification of seizures associated with neurocysticercosis: observations from a sample of seizure disorders in neurologic care in India. Acta Neurol Scand. 2006;13(4):233-40.

Antoniuk S, Bruck I, Santos LH, Souza LP, Fugimura S. Neurocysticercosis in children: clinical study and follow-up of 112 paitients. Rev Neurol. 2006;42:S97-01.

Gogia S, Talukdar B, Choudhury V, Arora BS. Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg. 2003;97(4):416-21.

Roman G, Sotelo J, Del Brutto O. A proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ. 2000;78(3):399-406.

Prasad KH, Prasad A, Verma A, Singh AK. Human cysticercosis an Indian scenario: A review. J Biosci. 2008;33(4):571-82.

Singhi P, Singhi S. Neurocycticercosis in children. Indian Journal of Pediatrics. 2009;76.

Del Brutto OH. Neurocysticercosis. Semin Neurol. 2005;25(3):243-51.

Gauchan E, Malla T, Basnet S, Rao KS. Variability of presentations and CT scan findings in children with neurocycticercosis. Kothmandu Univ. Med J. 2011;34(2):17-21.

Kraft R. Cysticercosis. An emerging parasitic disease. Am Fam Physician. 2007;76(1):91-6.

Palacio LG, Jimminez I, Garcia H. Neurocysticercosis in persons with epilepsy in Medellin, Columbia. Epilepsia. 1998;39(12):1334-9.

Carpio A. Neurocysticercosis. An update. Lancet Infect Dis. 2002;2:751-62.

Singh G, Ram S, Kaushal V, Kumar S, Bhatia RC, Raizada N. Risk of seizures and Neurocysticercosis in house hold family contacts of children with single enhancing leesions. J Neuro Sci. 2000;176:131-5.

Rajshekhar V, Chandy MJ. Validation of diagnostic criteria for solitary cerebral cysticercosis granuloma in patients presenting with seizures. Acta Neurol Scand. 1997;119:231-5.

Cao W, Van der Ploeg CP, Xu J, Ylquimiche L, Figueroa JJ, Rodriguez S, et al. Risk factors for human cysticercosis morbidity: A population based study. Epidmiol Infect. 1997;11:231-5.

Goodman KA, Ballagh SA, Carpio A. Case-control study of seropositivity for cysticercosis in Cuenca, Ecuador. Am J Trop Med Hyg. 1999;60(1):70-4.

Singh MV, Ichhpujani RL. Detection of antibodies to Taenia solium in sera of patients with epilepsy using ELISA. J Commun Dis. 2000;33:23-7.

Garg RK. Diagnostic criteria for neurocysticercosis; some modifications are needed for Indian patients. Neurol India. 2004;52:171-7.

White AC. Neurocysticercosis. Updates on epidemiology, pathogenesis, diagnosis, and management. Ann Rev Med. 2000;51:187-206.

Prasad KN, Prasad A, Gupta RK, Pandey CM, Singh U. Prevalence and associated risk factors of Taenia solium taeniasis in a rural pig farming community of north India. Trans R Soc Trop Med Hyg. 2007;101:1241-7.

Dhawan BK, Pediatric Neurocycticercosis. RusselW, Steel MD. Available in http://emed.medscape.com/article 99053 overview.